| First Author | Terzenidou ME | Year | 2017 |
| Journal | PLoS Genet | Volume | 13 |
| Issue | 4 | Pages | e1006656 |
| PubMed ID | 28376086 | Mgi Jnum | J:242350 |
| Mgi Id | MGI:5905075 | Doi | 10.1371/journal.pgen.1006656 |
| Citation | Terzenidou ME, et al. (2017) Novel insights into SLC25A46-related pathologies in a genetic mouse model. PLoS Genet 13(4):e1006656 |
| abstractText | The mitochondrial protein SLC25A46 has been recently identified as a novel pathogenic cause in a wide spectrum of neurological diseases, including inherited optic atrophy, Charcot-Marie-Tooth type 2, Leigh syndrome, progressive myoclonic ataxia and lethal congenital pontocerebellar hypoplasia. SLC25A46 is an outer membrane protein, member of the Solute Carrier 25 (SLC25) family of nuclear genes encoding mitochondrial carriers, with a role in mitochondrial dynamics and cristae maintenance. Here we identified a loss-of-function mutation in the Slc25a46 gene that causes lethal neuropathology in mice. Mutant mice manifest the main clinical features identified in patients, including ataxia, optic atrophy and cerebellar hypoplasia, which were completely rescued by expression of the human ortholog. Histopathological analysis revealed previously unseen lesions, most notably disrupted cytoarchitecture in the cerebellum and retina and prominent abnormalities in the neuromuscular junction. A distinct lymphoid phenotype was also evident. Our mutant mice provide a valid model for understanding the mechanistic basis of the complex SLC25A46-mediated pathologies, as well as for screening potential therapeutic interventions. |
